Matthias Will - 18 Mar 2026 Form 3 Insider Report for Autolus Therapeutics plc (AUTL)

Role
Chief Development Officer
Signature
/s/ Matthias Will
Issuer symbol
AUTL
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:59:46 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Will Matthias Chief Development Officer C/O AUTOLUS THERAPEUTICS PLC, THE MEDIAWORKS, 191 WOOD LN, WHITE CITY, LONDON, UNITED KINGDOM /s/ Matthias Will 18 Mar 2026 0002121979

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 800,000 $3.63 Direct F1
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 250,000 $1.89 Direct F2
holding AUTL Share Option (right to buy) 18 Mar 2026 American Depositary Shares 375,000 $1.46 Direct F3
holding AUTL Restricted Share Units 18 Mar 2026 American Depositary Shares 83,300 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested 25% on September 30, 2025 and the remainder vests in 36 equal monthly installments thereafter.
F2 This option vested 25% on March 14, 2026 and the remainder vests in 36 equal monthly installments thereafter.
F3 This option vests 25% on January 26, 2027 and the remainder vests in 36 equal monthly installments thereafter.
F4 The restricted share units ("RSUs") vest in four equal annual installments commencing on January 26, 2027.
F5 Each RSU represents a contingent right to receive one Issuer American Depositary Share.